Concept Life Sciences, a drug discovery, development and analytical services and environmental consultancy firm, has been acquired by Spectris plc, an instrumentation and controls company, for a purchase consideration of £163 million, on a debt and cash-free basis.   Concept represents a new, high-growth area for Spectris, and will become a separate operating company within its Materials Analysis segment, where it has synergies with Malvern Panalytical. Concept’s clients will have access to Ma...